MACOM Technology vs Revolution Medicines Inc. Common Stock — how do they compare? MACOM Technology trades at $330 (market cap $24.61B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Revolution Medicines Inc. Common Stock is more actively traded (4,855,734 versus 1,594,575). Which is the better fit depends on your goals — on Pluang, investors hold MACOM Technology for 6 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| MTSI | RVMD | |
|---|---|---|
Market Cap | $24.61B | $40.32B |
Volume | 1,594,575 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $409.68 | $221.15 |
52-Week Low | $122.18 | $47.50 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $24.32B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →